answers these and other crucial questions about this important developing field, one withvast commercial potential.
Comprehensive analysis of the global stem cells sector and market
Stem Cells – The Hype & Hope – World Analysis 2009-2024
examines stem cellstechnology critically. We used a comprehensive review of information sources, includingconsultations with relevant experts. This report provides detailed sales forecasts,discussions of pipeline developments and analyses of important contemporary issues,especially relevant commercial drivers and restraints. This report also covers regulationsand ethics. Sources used include commercial databases, industry news, published reports, policy documents and economic research. Importantly, visiongain applied rigorousfinancial forecasting, qualitative analyses and the assessment of unmet needs. The resultis a comprehensive market- and industry-centred report with detailed analysis andinformed opinion that you will not find elsewhere.
Why you should buy this report:
Key information that you will find in
Stem Cells – The Hype & Hope – World Analysis2009-2024
includes:• Analyses of the existing market value for stem cells• Analyses of the potential market value of stem cell therapies, including detailed revenueforecasts from 2009 to 2024• Forecasts for existing stem cell markets, including private cord blood banks and OsirisTherapeutics and NuVasive’s Osteocel• Discussions of ethical complications and situations that influence the way stem cellmedicine is perceived, researched and conducted• Analyses of key organisations, suppliers and relevant national laws• Expert opinions from original research interviews with key opinion leaders in stem cellsresearch and technology• Informed analyses of the strengths and weaknesses of the technologies from 2009onwards• Balanced assessments of commercial drivers and restraints in the stem cells field.• Visiongain believes that stem cell technologies are progressing rapidly. We predict thatmore products will enter the market over the coming 5 years, changing the commerciallandscape for stem cells.
You can order this report today
Nobody with an interest in the stem cells field can afford to overlook this new marketstudy from visiongain. The market environment in many countries will change, especiallyafter favourable developments in the US in early 2009. Visiongain predicts that revenuesfor stem cell technologies will increase greatly from 2009 to 2024, with important eventsshaping trends. Will stem cells revolutionise medicine in the foreseeable future? What arethe main obstacles to overcome there? What revenues can be achieved? This reportcovers those vital questions and many more. Do you want to know more about thisimportant market? You can stay ahead in this exciting field by ordering this report today.